siRNA, Anti-MAP3K9, 2'-F/2'-OMe/2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT11789WQ-2OMe)

The product SIRGT11789WQ-2OMe is a type of small interfering RNA (siRNA) that targets MAP3K9 gene and regulates the expression of gene. The siRNA interferes with the expression of MAP3K9 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001284230.1; NM_001284231.1; NM_001284232.1; NM_033141.3
Alternative Names MEKK9; MLK1; PRKE1
Related Diseases Retroperitoneum Carcinoma, Retroperitoneal Neuroblastoma
Purification HPLC
Target Gene
Gene ID 4293
Uniprot ID P80192
Sub Cat Target Species Modification Scale  
SIRGT12789WQ-2F MAP3K9 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT13789WQ-2MOE MAP3K9 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT11789WQ-RB MAP3K9 Human Ribo-modified Inquiry
SIRGT12789WQ-BB MAP3K9 Human Backbone-modified Inquiry

Related Products